Afficher la couverture 'What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies | Trégouët, David-Alexandre' en grand format
/5

0 avis

What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies

Archive ouverte

Trégouët, David-Alexandre | Morange, Pierre-Emmanuel

Edité par CCSD ; Wiley -

International audience. Venous thromboembolism (VTE) has a strong genetic component. This review summarizes what is known at the seventeen genes that are now well established to harbour VTE-associated genetic variants. In addition, it discusses additional candidate genes that deserve further validation before being claimed as VTE associated genes. Finally, several research strategies are briefly described to identify other molecular determinants of the disease.

Suggestions

Du même auteur

What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies

Archive ouverte | Trégouët, David-Alexandre | CCSD

International audience. The genetic contribution to the risk of venous thromboembolism (VTE) has been established since 1960s with the observation of an association of antithrombin deficiency and ABO blood type with...

High-Dimensional Multi-Block Analysis of Factors Associated with Thrombin Generation Potential

Archive ouverte | Lorenzo, Hadrien | CCSD

International audience. The identification of novel biological factors associated with thrombin generation, a key biomarker of the coagulation process, remains a relevant strategy to disentangle pathophysiological m...

Genetic determinants of tissue factor pathway inhibitor plasma levels

Archive ouverte | Dennis, Jessica | CCSD

International audience. Tissue factor pathway inhibitor (TFPI) impedes early stages of the blood coagulation response, and low TFPI plasma levels increase the risk of thrombosis. TFPI plasma levels are heritable, bu...

Chargement des enrichissements...